Explore more publications!
Educators Post Observer
Got News to Share?

Press Releases

Best Titanium Cutting Board for 2026: Microplastic Research and Material Analysis Shape Consumer Kitchen Decisions — TIBO
January 10, 2026

Best Titanium Cutting Board for 2026: Microplastic Research and Material Analysis Shape Consumer Kitchen Decisions — TIBO

Indeterminate GlobeNewswire, Inc.
Peer-reviewed study demonstrates LEON’s FR-JET® modular mixer enables stable high-concentration mRNA-LNPs with enhanced in vivo activity
January 9, 2026

Peer-reviewed study demonstrates LEON’s FR-JET® modular mixer enables stable high-concentration mRNA-LNPs with enhanced in vivo activity

Indeterminate GlobeNewswire, Inc.
Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium
January 9, 2026

Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium

Indeterminate GlobeNewswire, Inc.
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
January 9, 2026

MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026

Indeterminate GlobeNewswire, Inc.
MEXC Foundation Launches School Supplies Program in Agusan del Sur
January 9, 2026

MEXC Foundation Launches School Supplies Program in Agusan del Sur

Indeterminate GlobeNewswire, Inc.
Teachally Named 2026 Top EdTech for Curriculum and Instruction by District Administration
January 8, 2026

Teachally Named 2026 Top EdTech for Curriculum and Instruction by District Administration

Indeterminate GlobeNewswire, Inc.
O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated
January 9, 2026

O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated

Indeterminate GlobeNewswire, Inc.
Krystal Biotech Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study with Confirmation of Wild-Type CFTR Delivery to the Lungs of Patients with Cystic Fibrosis
January 8, 2026

Krystal Biotech Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study with Confirmation of Wild-Type CFTR Delivery to the Lungs of Patients with Cystic Fibrosis

Indeterminate GlobeNewswire, Inc.
Entrepreneurs’ Organization Birmingham Names Madison Hamilton as 2025 Global Student Entrepreneur Awards Finalist
January 8, 2026

Entrepreneurs’ Organization Birmingham Names Madison Hamilton as 2025 Global Student Entrepreneur Awards Finalist

Neutral EIN Presswire
Ontario Shores Launches North America’s First Recovery High School Program for Youth Mental Health
January 8, 2026

Ontario Shores Launches North America’s First Recovery High School Program for Youth Mental Health

Indeterminate GlobeNewswire, Inc.
Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen
January 8, 2026

Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen

Indeterminate GlobeNewswire, Inc.
Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria
January 8, 2026

Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria

Indeterminate GlobeNewswire, Inc.
Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones
January 8, 2026

Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones

Indeterminate GlobeNewswire, Inc.
Tisento Therapeutics Completes Enrollment in PRIZM, a Global Phase 2b Study of Zagociguat for the Treatment of MELAS
January 8, 2026

Tisento Therapeutics Completes Enrollment in PRIZM, a Global Phase 2b Study of Zagociguat for the Treatment of MELAS

Indeterminate GlobeNewswire, Inc.
AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)
January 8, 2026

AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)

Indeterminate GlobeNewswire, Inc.
GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary Fibrosis, Strengthening Clinical Proof-of-Concept for GRI-0621
January 8, 2026

GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary Fibrosis, Strengthening Clinical Proof-of-Concept for GRI-0621

Indeterminate GlobeNewswire, Inc.
Prositions Launches New Business Communication Course by Mark Jeffries
January 8, 2026

Prositions Launches New Business Communication Course by Mark Jeffries

Neutral EIN Presswire
SchoolAI Research Challenges Fears About AI in the Classroom with Evidence From 23,000 Teacher-Created Lessons
January 8, 2026

SchoolAI Research Challenges Fears About AI in the Classroom with Evidence From 23,000 Teacher-Created Lessons

Indeterminate GlobeNewswire, Inc.
Former Austin ISD Elementary Teacher Pleads Guilty to Possessing Child Sexual Abuse Material
January 6, 2026

Former Austin ISD Elementary Teacher Pleads Guilty to Possessing Child Sexual Abuse Material

Gov't Institution The U.S. Attorney's Office District of Puerto Rico
Owner: American Government

The U.S. Attorney's Office District of Puerto Rico

Gov't Institution
Owned By American Government
Year Founded 1870
Website www.justice.gov
Domain Registration Year Indeterminate
Access Type open
Publication Location Puerto Rico, San Juan
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

Lightz Out Studios Introduces Professional Headshot Service Serving Southern California
January 7, 2026

Lightz Out Studios Introduces Professional Headshot Service Serving Southern California

Neutral EIN Presswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions